D. Boral Capital to Present KOL Webinar Showcasing Insights and Innovations from Enlivex's Knee Osteoarthritis Program with Top Global Experts
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 29 2025
0mins
Source: Globenewswire
Webinar Announcement: Enlivex Therapeutics will host a live investor webinar on September 30, 2025, discussing advancements in knee osteoarthritis treatment, featuring key opinion leaders in musculoskeletal disease.
Positive Clinical Data: The webinar will highlight positive Phase IIa topline data from Enlivex’s Allocetra™ program, showing significant pain reduction and functional improvements in patients with moderate-to-severe knee osteoarthritis.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
